Journal of Pharmacology and Experimental Therapeutics: 260 (1)

January 01, 1992; Volume 260,Issue 1

You have access
Effect of chronic treatment with the calcium entry blocker, isradipine, on vascular calcium overload produced by vitamin D3 and nicotine in rats.
D Henrion, J M Chillon, C Capdeville-Atkinson and J Atkinson

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 1-8;
You have access
Comparison of mu opioid receptor binding on intact neuroblastoma cells with guinea pig brain and neuroblastoma cell membranes.
L Toll

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 9-15;
You have access
Regulation of 5-hydroxytryptamine1A receptor function in rat hippocampus by short- and long-term administration of 5-hydroxytryptamine1A agonist and antidepressants.
M E Newman, B Shapira and B Lerer

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 16-20;
You have access
Design of an irreversible affinity ligand for the phencyclidine recognition site on N-methyl-D-aspartate-type glutamate receptors.
S O Casalotti, A P Kozikowski, A Fauq, W Tückmantel and K E Krueger

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 21-28;
You have access
The acute renal actions of angiotensin converting enzyme inhibitors in the sodium-depleted conscious primate are mediated by inhibition of the renin-angiotensin system.
U Humke, N Levens, J Wood and K Hofbauer

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 29-35;
You have access
In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist: midazolam and flumazenil.
J W Mandema, E Tukker and M Danhof

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 36-44;
You have access
The sympathetic nervous system facilitates endothelin-1 effects on venous tone.
R P Waite and C C Pang

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 45-50;
You have access
Preclinical studies on LY237733, a potent and selective serotonergic antagonist.
M M Foreman, R W Fuller, D L Nelson, D O Calligaro, K D Kurz, J W Misner, W L Garbrecht and C J Parli

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 51-57;
You have access
Electrophysiological actions of the pimobendan metabolite, UD-CG 212 Cl, in guinea pig myocardium.
M V Westfall, G M Wahler, K Fujino and R J Solaro

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 58-63;
You have access
Comparison of the thrombolytic activity of the novel plasminogen activator, LY210825, to anisoylated plasminogen-streptokinase activator complex in a canine model of coronary artery thrombolysis.
C V Jackson, J D Frank, T J Craft, J L Sundboom and G F Smith

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 64-70;
You have access
Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemia.
W E Evans, J H Rodman, M V Relling, W P Petros, C F Stewart, C H Pui and G K Rivera

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 71-77;
You have access
Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats.
J H Kehne, T C McCloskey, V L Taylor, C K Black, G M Fadayel and C J Schmidt

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 78-89;
You have access
Receptor-coupled G proteins mediate contraction and Ca++ mobilization in isolated intestinal muscle cells.
K S Murthy, J R Grider and G M Makhlouf

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 90-97;
You have access
Omega-conotoxin-sensitive calcium channels modulate autonomic neurotransmission in guinea pig airways.
R J Altiere, L Diamond and D C Thompson

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 98-103;
You have access
Cyclooxygenase dependency of the renovascular actions of cytochrome P450-derived arachidonate metabolites.
M A Carroll, M P Garcia, J R Falck and J C McGiff

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 104-109;
You have access
Block of sodium channel current by anticonvulsant U-54494A in mouse neuroblastoma cells.
Y Zhu and W B Im

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 110-116;
You have access
A proposed mechanism of action for the antinociceptive effect of intrathecally administered calcium in the mouse.
S P Welch, D L Stevens and W L Dewey

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 117-127;
You have access
Effect of 3'-azido-3'-deoxythymidine (AZT) on organic ion transport in rat renal brush border membrane vesicles.
D A Griffiths, S D Hall and P P Sokol

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 128-133;
You have access
Characterization of receptors involved in dopamine-induced activation of phospholipase-C in rat renal cortex.
S J Vyas, J Eichberg and M F Lokhandwala

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 134-139;
You have access
Antagonists of nitric oxide synthesis inhibit nerve-mediated relaxations of longitudinal muscle in guinea pig ileum.
L E Osthaus and J J Galligan

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 140-145;
You have access
Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
A A Megens, F H Awouters, T F Meert, K H Schellekens, C J Niemegeers and P A Janssen

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 146-159;
You have access
Behavioral disinhibition and depression in amphetaminized rats: a comparison of risperidone, ocaperidone and haloperidol.
A A Megens, C J Niemegeers and F H Awouters

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 160-167;
You have access
Paradoxical effect of chronic fentanyl treatment on naltrexone-induced supersensitivity and upregulation.
F J Ayesta, A Ableitner, M W Emmett-Oglesby, A Herz and T S Shippenberg

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 168-174;
You have access
Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566.
R M Edwards, N Aiyar, E H Ohlstein, E F Weidley, E Griffin, M Ezekiel, R M Keenan, R R Ruffolo and J Weinstock

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 175-181;
You have access
After GM1 ganglioside treatment of sensory neurons naloxone paradoxically prolongs the action potential but still antagonizes opioid inhibition.
S M Crain and K F Shen

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 182-186;
You have access
Multiple actions of the leukotriene B4 receptor antagonist SC-41930.
D Villani-Price, D C Yang, R E Walsh, D J Fretland, R H Keith, G Kocan, J F Kachur, T S Gaginella and B S Tsai

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 187-191;
You have access
Evidence for a noradrenergic innervation to "atypical" beta adrenoceptors (or putative beta-3 adrenoceptors) in the ileum of guinea pig.
D T Taneja and D E Clarke

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 192-200;
You have access
Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents.
D R Compton, M R Johnson, L S Melvin and B R Martin

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 201-209;
You have access
Chronic marijuana smoke exposure in the rhesus monkey. II: Effects on progressive ratio and conditioned position responding.
M G Paule, R R Allen, J R Bailey, A C Scallet, S F Ali, R M Brown and W Slikker

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 210-222;
You have access
In vivo evaluation of the antagonist activity of angiotensin I analogs.
E K Jackson

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 223-231;
You have access
N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization.
A Pittaluga and M Raiteri

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 232-237;
You have access
N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. II. Evidence for functional cooperation and for coexistence on the same axon terminal.
M Raiteri, B Garrone and A Pittaluga

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 238-242;
You have access
Effect of long-acting calcium entry blocker (anipamil) on blood pressure, renal function and survival of uremic rats.
C Jarusiripipat, L Chan, J I Shapiro and R W Schrier

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 243-247;
You have access
Different mechanisms of relaxation of pig coronary artery to bradykinin and cromakalim are distinguished by potassium channel blockers.
C L Cowan and R A Cohen

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 248-253;
You have access
Effects of diazoxide and glyburide on ATP-sensitive K+ channels from hypertrophied ventricular myocytes.
F Ciampolillo, D E Tung and J S Cameron

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 254-260;
You have access
Cromakalim effects of acetylcholine-induced changes in cytosolic calcium and tension in swine trachealis.
C C Shieh, M F Petrini, T M Dwyer and J M Farley

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 261-268;
You have access
Effect of fenoldopam on the acute and subacute nephrotoxicity produced by amphotericin B in the dog.
A J Nichols, P F Koster, D P Brooks and R R Ruffolo

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 269-274;
You have access
Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.
R B Raffa, E Friderichs, W Reimann, R P Shank, E E Codd and J L Vaught

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 275-285;
You have access
Lack of tolerance to a 24-hour infusion of S-nitroso N-acetylpenicillamine (SNAP) in conscious rabbits.
J E Shaffer, B J Han, W H Chern and F W Lee

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 286-293;
You have access
Effects of captopril on blood pressure, placental blood flow and uterine oxygen consumption in pregnant rabbits.
N D Binder and J J Faber

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 294-299;
You have access
Anti-inflammatory activity of BF389, a Di-T-butylphenol, in animal models of arthritis.
A M Bendele, D N Benslay, J T Hom, S M Spaethe, K J Ruterbories, T D Lindstrom, S J Lee and R W Naismith

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 300-305;
You have access
Differential inhibition of cholinergic and noncholinergic neurogenic contractions by 5-hydroxytryptamine1A receptor agonists in guinea pig ileum.
J J Galligan

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 306-312;
You have access
Misoprostol accelerates colonic mucosal repair in acetic acid-induced colitis.
T Yamada, K Fujimoto, P Tso, T Fujimoto, T S Gaginella and M B Grisham

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 313-318;
You have access
The biochemistry and pharmacology of PD 116124 (8-amino-2'-nordeoxyguanosine), an inhibitor of purine nucleoside phosphorylase (PNP).
M K Dong, M E Scott, D J Schrier, M J Suto, J C Sircar, A Black, T Chang and R B Gilbertsen

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 319-326;
You have access
Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.
R M Craft and L A Dykstra

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 327-333;
You have access
Agonist and antagonist activity of kappa opioids in the squirrel monkey: II. Effect of chronic morphine treatment.
R M Craft and L A Dykstra

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 334-342;
You have access
Cholecystokinin release from the rat caudate-putamen, cortex and hippocampus is increased by activation of the D1 dopamine receptor.
J S Brog and M C Beinfeld

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 343-348;
You have access
Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure.
R W Lee, T E Raya, U Michael, S Foster, T Meeks and S Goldman

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 349-354;
You have access
Clinical characteristics of naloxone-precipitated withdrawal in human opioid-dependent subjects.
P D Kanof, L Handelsman, M J Aronson, R Ness, K J Cochrane and K J Rubinstein

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 355-363;
You have access
Opposite effects of enantiomers of clofibric acid derivative on rat skeletal muscle chloride conductance: antagonism studies and theoretical modeling of two different receptor site interactions.
A De Luca, D Tricarico, R Wagner, S H Bryant, V Tortorella and D Conte Camerino

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 364-368;
You have access
Effects of the amphiphilic peptides melittin and mastoparan on calcium influx, phosphoinositide breakdown and arachidonic acid release in rat pheochromocytoma PC12 cells.
O H Choi, W L Padgett and J W Daly

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 369-375;
You have access
Use-, concentration- and voltage-dependent limitation by MK-801 of action potential firing frequency in mouse central neurons in cell culture.
A W Wamil and M J McLean

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 376-383;
You have access
Characterization of kinin receptors on human synovial cells and upregulation of receptor number by interleukin-1.
J M Bathon, D C Manning, D W Goldman, M C Towns and D Proud

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 384-392;
You have access
Methimazole protection of rats against chemically induced kidney damage in vivo.
P J Sausen, A A Elfarra and A J Cooley

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 393-401;
You have access
Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression.
M Morelli, S Fenu, A Pinna and G Di Chiara

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 402-408;
You have access
D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists.
K X Huang and J R Walters

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 409-416;
You have access
The insulin-secreting cell line, RINm5F, expresses an alpha-2D adrenoceptor and nonadrenergic idazoxan-binding sites.
A Remaury and H Paris

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 417-426;
You have access
[3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding.
S M Tejani-Butt

Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 427-436;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals